Latest on Pharmaceutical Industry



15th Annual Pharma Forum 2019

New York Marriott Marquis,


19th Annual Medicinal & Pharmaceutical Sciences Congress

Courtyard by Marriott Hong Kong,
Hong Kong,
Conference Series LLC Ltd


3rd Product Complaints Forum

The Inn at Penn, A Hilton Hotel,
United States,
ExL Events, Inc.


Medical Device Safety & Reporting Summit

The Inn at Penn, a Hilton Hotel,
United States,
ExL Events, Inc.

Press Releases

Millendo Therapeutics Initiates Pivotal Phase 2b/3 Clinical Study of Livoletide for the Treatment of Prader-Willi Syndrome

Millendo Therapeutics Inc a clinicalstage biopharmaceutical company developing novel treatments for orphan endocrine diseases announced today that it has initiated its pivotal Phase 2b3 clinical study investigating livol.. Read More...

Amphastar Pharmaceuticals Receives FDA Approval for Enoxaparin Sodium Injection 300mg/3mL (100mg/mL) Multiple Dose Vial

Amphastar Pharmaceuticals Inc announced that the US Food and Drug Administration FDA granted approval of its Abbreviated New Drug Application ANDA for Enoxaparin Sodium Injection 300mg3mL 100mgmL Multiple Dose Vial MDV T.. Read More...

Suppliers of the Month

Product Launch



Latest Reports


Latest Projects


Expert Talk

Messe Muenchen India Pvt. Ltd.

Messe Muenchen India Pvt. Ltd. As per the World Bank India has made a substantial effort in attempting to address environmental challenges It has endorsed rigorous environmental legislation and has created relevant institutions to monitor and enforce legislation In response to the threat of climate change the Prime Ministers Nati. Read More...
Bhupinder Singh
Chief Executive Officer